IMIPENEM AND CILASTATIN (CILASTATIN SODIUM; IMIPENEM) — FDA Approval ANDA090825 (HOSPIRA INC)
IMIPENEM AND CILASTATIN (CILASTATIN SODIUM; IMIPENEM) — FDA Approval ANDA090825 (HOSPIRA INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IMIPENEM AND CILASTATIN; Active ingredients: CILASTATIN SODIUM; IMIPENEM; Application number: ANDA090825.
| Brand name | IMIPENEM AND CILASTATIN |
|---|---|
| Active ingredients | CILASTATIN SODIUM; IMIPENEM |
| Application number | ANDA090825 |
| Sponsor | HOSPIRA INC |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20111116 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →